RESEARCH TRIANGLE PARK, N.C. – Marken, the clinical supply chain subsidiary of UPS Healthcare, is adding a GMP-compliant depot in Los Angeles, California, and a new GMP-compliant depot in Kiev, Ukraine.
In addition, two GDP-compliant logistics branches will be added in Dublin, Ireland, and Amsterdam, the Netherlands.
The Amsterdam facility will include a cryogenic filling station to meet the growing need of Marken’s cell and gene therapy clients. An additional LN2 service station has been added to Marken’s network in Geneva, Switzerland.
By early Q4, Marken will have 12 fully operational GMP-compliant depot locations, and more than 10 million square feet of GMP-validated commercial warehouse space in 56 UPS Healthcare distribution centres.
According to Wes Wheeler, UPS Healthcare’s president, the company plans continued investments in Marken as the pharmaceutical industry expands into new regions of the world.
Marken has a GMP-compliant depot network and logistic hubs in 54 locations worldwide for clinical trial product storage and distribution.